Oxford Biomedica plc (OTCMKTS:OXBDF) Sees Large Growth in Short Interest

Oxford Biomedica plc (OTCMKTS:OXBDF) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 247,000 shares, an increase of 83.5% from the March 15th total of 134,600 shares. Currently, 0.2% of the company’s stock are sold short. Based on an average trading volume of 200 shares, the short-interest ratio is currently 1,235.0 days.

Oxford Biomedica Price Performance

Oxford Biomedica stock traded up $0.97 during mid-day trading on Friday, reaching $4.12. 1,000 shares of the company traded hands, compared to its average volume of 6,035. The firm’s fifty day moving average is $3.94 and its two-hundred day moving average is $4.78. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. Oxford Biomedica has a fifty-two week low of $2.62 and a fifty-two week high of $5.68.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.